Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRFT
1151
DELISTED
Perficient Inc
PRFT
| $81.9M | 0.01% |
1,172,504
+661,997
| +130% | +$45.7M |
|
1152
STMicroelectronics
STM
$46.7B
| $81.8M | 0.01% |
2,300,657
-121,966
| -5% | -$4.3M |
|
1153
Camden Property Trust
CPT
$11B
| $81.8M | 0.01% |
730,932
-80,328
| -10% | -$9.19M |
|
1154
Goldman Sachs Future Tech Leaders Equity ETF
GTEK
$226M
| $81.7M | 0.01% |
3,906,500
+493,450
| +14% | +$10.5M |
|
1155
Goldman Sachs Future Health Care Equity ETF
GDOC
$17.9M
| $81.5M | 0.01% |
2,593,777
-309,300
| -11% | -$9.56M |
|
1156
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.04B
| $81.5M | 0.01% |
4,614,676
+103,027
| +2% | +$1.86M |
|
|
IBDP
1157
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
| $81.5M | 0.01% |
3,335,748
+53,547
| +2% | +$1.3M |
|
1158
Insight Enterprises
NSIT
$3.89B
| $81.4M | 0.01% |
811,951
+476,084
| +142% | +$45.5M |
|
1159
Check Point Software Technologies
CHKP
$13B
| $81.3M | 0.01% |
644,770
+75,826
| +13% | +$9.46M |
|
1160
iShares US Oil & Gas Exploration & Production ETF
IEO
$580M
| $81.3M | 0.01% |
875,832
+34,597
| +4% | +$3.36M |
|
1161
Herbalife
HLF
$1.29B
| $81.3M | 0.01% |
5,463,022
+2,757,443
| +102% | +$48M |
|
1162
BlackRock Enhanced Global Dividend Trust
BOE
$673M
| $81.2M | 0.01% |
8,498,156
-517,465
| -6% | -$4.86M |
|
1163
Independent Bank
INDB
$3.99B
| $81.2M | 0.01% |
961,843
+688,062
| +251% | +$58.3M |
|
|
GSFP
1164
DELISTED
Goldman Sachs Future Planet Equity ETF
GSFP
| $81.2M | 0.01% |
2,765,977
-172,100
| -6% | -$5M |
|
1165
Houlihan Lokey
HLI
$8.77B
| $81.2M | 0.01% |
931,264
+522,178
| +128% | +$46.9M |
|
|
CYBR
1166
DELISTED
CyberArk
CYBR
| $81.1M | 0.01% |
625,621
-8,204
| -1% | -$1.19M |
|
|
GBUY
1167
DELISTED
Goldman Sachs Future Consumer Equity ETF
GBUY
| $81.1M | 0.01% |
3,488,371
+224,500
| +7% | +$5.21M |
|
1168
Minerals Technologies
MTX
$2.36B
| $81M | 0.01% |
1,334,204
+1,064,915
| +395% | +$60.3M |
|
|
VSXY
1169
Victoria's Secret
VSXY
$7.05B
| $81M | 0.01% |
2,263,928
-583,298
| -20% | -$23.2M |
|
|
ARNC
1170
DELISTED
Arconic Corporation
ARNC
| $81M | 0.01% |
3,826,023
+228,875
| +6% | +$4.79M |
|
|
NARI
1171
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $81M | 0.01% |
1,273,630
+1,019,378
| +401% | +$73.9M |
|
|
AZEK
1172
DELISTED
The AZEK Co
AZEK
| $80.7M | 0.01% |
3,973,475
+2,906,460
| +272% | +$53.8M |
|
1173
Globus Medical
GMED
$10.7B
| $80.7M | 0.01% |
1,086,289
-123,962
| -10% | -$8.44M |
|
1174
Quaker Houghton
KWR
$2.79B
| $80.5M | 0.01% |
482,199
+361,525
| +300% | +$60.8M |
|
1175
Bio-Rad Laboratories Class A
BIO
$8.71B
| $80.4M | 0.01% |
191,121
+53,491
| +39% | +$21.6M |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 200 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 200 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.